Ibrutinib plus venetoclax in relapsed/refractory CLL: results of the Bloodwise TAP CLARITY study
Hillmen, P Rawstron, A Brock, K Vicente, M Yates, F Bishop, R Macdonald, D Fegan, C McCaig, A Schuh, A
Hillmen, P
Rawstron, A
Brock, K
Vicente, M
Yates, F
Bishop, R
Macdonald, D
Fegan, C
McCaig, A
Schuh, A
Citations
Altmetric:
Abstract
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Hillmen P, Rawstron A, Brock K, Vicente S, Yates F, Bishop R, et al. Ibrutinib plus venetoclax in relapsed/refractory CLL: results of the Bloodwise TAP CLARITY study. Blood. 2018;132.